SCHEMBL6928534

SCHEMBL6928534

CC1=CC(C)(C)Nc2ccc3c(c21)c(=O)oc1cccc(O)c13

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 15/20 0.55
▸ NR3C1 P04150 7/20 0.41
▸ AR P10275 2/20 0.41
▸ MAOA P21397 2/20 0.36
▸ NR3C2 P08235 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6723833 0.99 PGR (0.54) PGRNR3C1ARMAOANR3C2
SCHEMBL6720477 0.86 PGR (0.49) PGRNR3C1ARNR3C2
SCHEMBL2397969 0.85 PGR (0.57) PGRNR3C1ARMAOA
SCHEMBL2393047 0.84 PGR (0.73) PGRNR3C1ARNR3C2
SCHEMBL5032324 0.84 PGR (0.53) PGRNR3C1ARNR3C2
SCHEMBL6294955 0.83 PGR (0.52) PGRNR3C1ARNR3C2
SCHEMBL4160644 0.82 AR (0.53) PGRNR3C1ARNR3C2
SCHEMBL1315813 0.81 ESR1 (0.53) PGRMAOA
SCHEMBL5034870 0.81 PGR (0.51) PGRNR3C1ARMAOANR3C2
SCHEMBL7113533 0.79 PGR (0.47) PGRNR3C1ARNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069427-A1 Process for the preparation of 5-(substituted)-10 methoxy-2,2,4-trimethyl-2,5-dihydro- 1H-chromeno [3,4-f] quinolines and derivatives thereof ABBVIE INC. 2003-04-10 — — US claimed
WO-2003027117-A1 A PROCESS FOR THE PREPARATION OF 5-(SUBSTITUTED)-10-METHOXY-2,2,4-TRIMETHYL-2,5-DIHYDRO-1H-CHROMENO[3,4-F]QUINOLINES AND DERIVATIVES THEREOF ABBOTT LABORATORIES (US) 2003-04-03 — — WO claimed
US-6518430-B1 The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5- dihydro-1H-chromeno(3,4-f)quinolines. ABBOTT LABORATORIES 2003-02-11 — — US claimed
US-20220280661-A1 GLUCOCORTICOID RECEPTOR RADIOLIGANDS AND METHODS FOR THEIR PREPARATION AND USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-09-08 — — US disclosed
WO-2021118728-A2 GLUCOCORTICOID RECEPTOR RADIOLIGANDS AND METHODS FOR THEIR PREPARATION AND USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-06-17 — — WO disclosed
WO-2021118728-A2 GLUCOCORTICOID RECEPTOR RADIOLIGANDS AND METHODS FOR THEIR PREPARATION AND USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-06-17 — — WO disclosed
US-6608216-B2 Preparing biaryl atropisomers; chirality transfer from stereogenic center of secondary alcohol to biaryl stereogenic axis via regioselective intramolecular migration ABBOTT LABORATORIES 2003-08-19 — — US disclosed
US-20030073844-A1 Process for the preparation of chiral glucocorticoid receptor agents ABBOTT LABORATORIES 2003-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073844-A1 Process for the preparation of chiral glucocorticoid receptor agents NR3C1, NR3C2, MC2R PGR 286/4885NR3C1 1/4885AR 35/4885
US-20030069427-A1 Process for the preparation of 5-(substituted)-10 methoxy-2,2,4-trimethyl-2,5-dihydro- 1H-chromeno [3,4-f] quinolines and derivatives thereof HTR3C, CYP3A5, NQO2 PGR 3676/4885NR3C1 4111/4885AR 3247/4885
US-20220280661-A1 GLUCOCORTICOID RECEPTOR RADIOLIGANDS AND METHODS FOR THEIR PREPARATION AND USE NR3C1, NR3C2, MC2R PGR 116/4885NR3C1 1/4885AR 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback